Seufert Rechtsanwälte advised RHÖN KLINIKUM AG on taking over 75.1% of the shares in Marburger Ionenstrahl-Therapiezentrum (MIT GmbH). RHÖN will, subject to certain conditions precedent, become sole shareholder on 1 January 2019 and will, by this step, ensure unrestricted continuation of patient treatment.